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Abstract
 
In contrast with the 
 
  
 
 T cell receptor (TCR), the pre-TCR spontaneously segregates to
membrane rafts from where it signals in a cell-autonomous fashion. The disparate behaviors of
these two receptors may stem either from differences inherent to the distinct developmental
stages during which they are expressed, or from features intrinsic and unique to the receptor
components themselves. Here, we express TCR
 
 
 
 precisely at the pre-TCR checkpoint, at levels
resembling those of endogenous pre-TCR
 
  
 
(pT
 
 
 
), and in the absence of endogenous pT
 
 
 
.
Both in isolation and more dramatically when in competition with pT
 
 
 
, TCR
 
 
 
 induced defective
proliferation, survival, and differentiation of 
 
  
 
 T lymphocyte precursors, as well as impaired
commitment to the 
 
  
 
 T lymphocyte lineage. Substitution of TCR
 
 
 
 transmembrane and
cytoplasmic domains with those of pT
 
 
 
 generated a hybrid molecule possessing enhanced
competitive abilities. We conclude that features intrinsic to the pre-TCR, which are absent in
TCR
 
 
 
, are essential for its unique function.
Key words: T lymphocyte subsets • cell lineage • receptor-mediated signal transduction • 
receptor antigen • T-cell 
 
  
 
Introduction
 
Thymocytes harboring a productive rearrangement at the
TCR
 
 
 
 locus generate a TCR
 
 
 
 molecule that pairs covalently
with the invariant pre-TCR
 
 
 
 (pT
 
 
 
) and noncovalently
with CD3 signal–transducing molecules, resulting in forma-
tion of a pre-TCR complex at the cell surface. The failure to
identify an extracellular ligand for the pre-TCR, as well as
the functional capabilities of a mutant pre-TCR complex
lacking all extracellular domains (1), could indicate that
pre-TCR signaling may be initiated in a manner independent
of extracellular ligation. Indeed, pre-TCR complexes on the
surface of a SCID murine thymoma cell line localize to
membrane rafts, from where they signal in a cell-autonomous
fashion (2). The ensuing phosphorylation and activation of
p56
 
Lck
 
 and ZAP-70 (2), mobilization of intracellular Ca
 
2
 
 
 
stores (3), and nuclear translocation of nuclear factor 
 
 
 
B and
NFAT transcription factors (3, 4) presumably mediate survival,
proliferation, differentiation, and TCR
 
 
 
 allelic exclusion
during 
 
   
 
T lymphocyte development (5). The constitutive
internalization and ubiquitin-mediated proteasome-dependent
degradation of the pre-TCR complex terminates this signal
transduction process (6, 7).
In sharp contrast, TCR
 
  
 
 complexes localize to membrane
rafts, from where they trigger signal transduction cascades
only in response to stimulation with costimulatory molecules
and agonist peptides presented by MHC molecules (8, 9).
Like the pre-TCR, TCR
 
  
 
 complexes are constitutively
internalized. However, in contrast to the pre-TCR, unstimu-
lated TCR
 
  
 
 complexes are recycled back to the cell surface
(10, 11). Only in response to stimulation are internalized
TCR
 
  
 
 complexes degraded (12).
The lack of pre-TCR-induced survival, proliferation,
and differentiation is evident in 
 
pT
 
 
 
   
 
 mice, even though
some cells still pass the pre-TCR-controlled checkpoint by
virtue of their ability to form TCR
 
  
 
 and TCR
 
  
 
 com-
plexes (13, 14). Whether or not a TCR
 
 
 
 molecule can
functionally replace pT
 
 
 
 in the pre-TCR complex is a
matter of considerable controversy.
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, pre-TCR
 
 
 
; WTpT
 
 
 
, wild-type pT
 
 
 
. 
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One view suggests that the cell-autonomous nature of
pre-TCR signaling is dependent on the identity of the
TCR
 
 
 
 partner component. Several papers document that,
in contrast with pre-TCR expression, premature expression
of a TCR
 
  
 
 complex promotes a “
 
  
 
-like” T cell lineage
fate, and results in impaired proliferation and differentiation
to the CD4
 
 
 
8
 
 
 
 stage of thymocyte development (15–18).
More specifically, some evidence has implicated the cyto-
plasmic domain unique to pT
 
 
 
 as essential for pre-TCR
function. Provision of a wild-type pT
 
 
 
 transgene to 
 
pT
 
 
 
 
 
/
 
 
 
mice restored pre-TCR-induced proliferation, survival, and
differentiation better than a transgene lacking the pT
 
 
 
 cyto-
plasmic domain or the proline-rich regions thereof (19).
Pulse chase experiments documented cell-autonomous in-
ternalization and degradation of TCR and CD3
 
 
 
 surface re-
ceptor components in cell lines expressing pre-TCR com-
ponents, but not in those expressing TCR
 
  
 
 or TCR
 
  
 
components (7). Mutagenesis studies identified the cytoplas-
mic domain of human pT
 
 
 
 as essential for cell-autonomous
receptor internalization and degradation (6). These latter
studies further implied that cell-autonomous constitutive in-
ternalization might represent one mechanism by which pre-
TCR surface expression and signaling is self-regulated. An
apparent requirement for strict regulation of surface expres-
sion level may also exist in the analogous cell-autonomous
pre–B cell receptor signaling cascade (20).
The alternative view implies that the cell-autonomous
nature of pre-TCR signaling depends on the developmen-
tal stage at which the receptor is expressed rather than on
qualities inherent to the TCR
 
 
 
 partner component itself.
This view suggests that pT
 
 
 
 represents merely a “surrogate
TCR
 
 
 
 molecule,” whose function is restricted to stabiliz-
ing surface expression of a productively rearranged TCR
 
 
 
molecule. Indeed, a recent paper implicated elevated raft
content, stronger capacitative Ca
 
2
 
 
 
 entry, and increased ex-
tracellular signal-related kinase activation as factors generat-
ing a unique developmental environment in CD4
 
 
 
8
 
 
 
 dou-
ble negative (DN) 3 thymocytes (21).
Thus far, observations concerning the potential inter-
changeability of pT
 
 
 
 and TCR
 
 
 
 have been inconclusive.
Utilization of TCR
 
 
 
 and TCR
 
 
 
 transgenes (14, 16–18),
or a TCR
 
 
 
 transgene expressed at developmental stages
different from those of endogenous pT
 
 
 
 (15, 22), has pre-
cluded a direct assessment of the performance of a TCR
 
 
 
molecule expressed at precisely the same developmental
stage as that of endogenous pT
 
 
 
. Although controlled by
the p56
 
Lck
 
 proximal promoter, the wide variation among
founders in the expression of transgenes encoding either
pT
 
 
 
 or pT
 
 
 
 substituted with the connecting peptide,
transmembrane, and cytoplasmic domains of TCR
 
 
 
 made
difficult a comparison between these two transgenes (23).
The proliferative potential of 
 
pT
 
 
 
 
 
/
 
 
 
 fetal thymocytes ret-
rovirally transduced with either pT
 
 
 
 or TCR
 
 
 
 may have
been obscured by analysis of their proliferation in fetal thy-
mic lobes (21), which is much reduced when compared
with that of thymocytes developing in situ. Finally, analyses
of the reconstitution of empty adult or fetal thymi in which
there is no competition for resources or niche space may
grossly overestimate the ability of TCR
 
 
 
 molecules to
mimic the functions of pT
 
 
 
.
Here, we analyze the interchangeability of WTpT
 
 
 
(WTpT
 
 
 
) with TCR
 
 
 
, and with a TCR
 
 
 
/pT
 
 
 
 hybrid
molecule consisting of the extracellular domain of TCR
 
 
 
joined to the transmembrane and cytoplasmic domains of
pT
 
 
 
. By placing each transgene under the control of the
p56
 
Lck
 
 proximal promoter, we ensured that each potential
TCR
 
 
 
 partner component is expressed at an equal and rel-
evant stage of thymocyte development. By crossing each
transgene onto the 
 
pT
 
 
 
 
 
/
 
 
 
 genetic background, we al-
lowed each receptor to perform in the absence of endoge-
nous pT
 
 
 
. Furthermore, by introducing equal numbers of
precursors expressing different receptors into a single thy-
mus, we forced them to compete for available space and re-
sources, revealing differences in receptor function that may
be obscured by analyses of the developmental potential of
cells that express only a single type of receptor in a non-
competitive environment.
We found that the TCR
 
 
 
 molecule was unable to fully
restore the proliferation, survival, differentiation and 
 
  
 
 T
cell lineage commitment induced by the WTpT
 
 
 
 mole-
cule. When placed in direct competition, the superiority of
WTpT
 
 
 
 became more dramatically apparent with regard
to proliferation and progression to the CD4
 
 
 
8
 
 
 
 stage of
thymocyte development. Substitution of the transmem-
brane and cytoplasmic domains of TCR
 
 
 
 with those of
pT
 
 
 
 generated a TCR
 
 
 
/pT
 
 
 
 hybrid molecule exhibiting
enhanced performance in competition with WTpT
 
 
 
 when
compared with TCR
 
 
 
, supporting the view that some of
the cell-autonomous nature of pre-TCR signaling is be-
stowed on the complex by properties unique and intrinsic
to the pT  molecule.
Materials and Methods
Mice and Cell Lines.  C57Bl/6 and Rag /  c /  mice were
purchased from Taconic Farms. pT  /  mice were generated as
described previously (13). All mice were kept in specific patho-
gen-free animal facilities at the Dana-Farber Cancer Institute. All
animal procedures were performed in compliance with the
guidelines of the Dana-Farber Cancer Institute Animal Resources
Facility, which operates under regulatory requirements of the
U.S. Department of Agriculture and Association for Assessment
and Accreditation of Laboratory Animal Care. The 58     T
cell hybridoma (provided by F. Grassi, Institute for Research in
Biomedicine, Bellinzona, Switzerland; reference 28) was main-
tained in IMDM containing 10% FBS, penicillin-streptomycin,
and 0.1%  -mercaptoethanol.
Generation of Transgenic Mice.  WTpT  and pT -PRO 
transgenic mice were generated as described previously (19, 24).
The TCR /pT  hybrid construct was generated by PCR of
an N15 TCR  cDNA template with the primers TCRaBamup,
5 -ACGGATCCTTTCCACCATGAACATGCGTCC-3 , and
TCRalo, 5 -AGGAATTCTGAAAGTTTAGGTTCATATCTGT-
3 ; and a pT  cDNA template with the primers pTaEcoup, 5 -
CAGAATTCCTGGCTGAGCCTACTGCGCCTGCT-3 , and
pTaBamlo, 5 -TGGGATCCAGGGGTGGGTAAGATCTAA-3 .Borowski et al. 609
The two amplification products were cut with EcoRI, and the cohe-
sive EcoRI sites were fused. cDNA encoding the TCR  chain of
the N15 TCR (provided by L. Clayton, Dana-Farber Cancer Insti-
tute, Boston, MA) was inserted pUC1017 vector, 3  to the p56Lck
proximal promoter. p56Lck proximal promoter TCR  or TCR /
pT  hybrid-hGH minigene fragments released by NotI digestion
were microinjected into fertilized eggs. Founders were screened for
transgene insertion by amplification of tail DNA with the primers
lckp, 5 -AACCCAGTCAGGAGCTTGAA-3 ; mus3, 5 -CATC-
GAGCAGAAGCAGTTTGA-3 ; and TCRalo. pT  deficiency
was assessed by amplification of tail DNA with the primers pTaF,
5 -TCACAGTGCTGGTAGATGGAAGG-3 ; pTaKOR, 5 -
GTTTGCTCGACATTGGGTGG-3 ; and pTaWTR, 5 -GGCT-
CAAGAGATAACCTGAACCATG-3 .
Antibodies and Reagents.  Anti-CD8, anti-CD4, anti-
TCR  , anti-TCR , anti-CD25, anti-CD44, anti-CD24 (heat-
stable antigen [HSA]), anti–Gr-1, anti–Ter-119, anti-Dx5, anti-
CD19, anti-CD3 , anti-CD45.1, anti-CD45.2, and Annexin V
were purchased from BD Biosciences. Each mAb was either
biotinylated or directly conjugated to FITC, PE, cychrome, or
allophycocyanin fluorophores. Cychrome- or allophycocyanin-
conjugated streptavidin (BD Biosciences) was used to reveal
staining with biotinylated mAbs. Surface staining of thymocytes
and BM was performed as described previously (14, 19). Cells
were analyzed using a FACSCalibur™ flow cytometer (Becton
Dickinson) and sorted using a MoFlo cell sorter (DakoCytoma-
tion). Propidium iodide was obtained from Sigma-Aldrich.
RT-PCR.  High pure RNA isolation kit (Roche) was used
to isolate thymocyte RNA. SuperScript First-strand Synthesis
System for RT-PCR (Invitrogen) was used to generate cDNA.
Fivefold serial dilutions of cDNA were used for semi-quantitative
PCR analysis of transgene and actin levels with the primers lckp;
mus3; A2, 5 GGCACCCCCTTTCCGTCTCT-3 ; TCRalo;
actinup, 5 -TGGAATCCTGTGGCATCCATGAAAC-3 ; and
actinlo, 5 -TAAAACGCAGCTCAGTAACAGTCCG-3 .
Competition Assay.  BM cells lacking the lineage markers Gr-1,
Ter-119, Dx5, CD19, TCR , and CD3  were sorted from
WTpT , TCR , TCR /pT  hybrid, pT -PRO , and pT  / 
mice. 1–2   105 cells of each population were mixed and in-
jected intravenously into the tail vein of each irradiated (500 rad)
Rag /  c /  mouse. Thymic reconstitution was analyzed 5 wk
after injection.
Retroviral Infection.  WTpT , TCR , or TCR /pT  hybrid
constructs, upstream of an internal ribosomal entry site and en-
hanced green fluorescent protein (EGFP; CLONTECH Labora-
tories, Inc.), were cloned into a modified Moloney murine leu-
kemia virus-based retroviral vector (provided by R. Mulligan,
Children’s Hospital, Boston, MA). Retroviral supernatants were
generated as described previously (19). 105 58     T cell hy-
bridoma cells were infected on ice for 3 h in the presence of 8
 g/ml polybrene.
Online Supplemental Material.  Surface expression of TCR 
protein on CD4 CD8 CD25 CD44  (DN3) thymocytes from
WTpT  and transgenic mice was analyzed using anti-TCR 
from BD Biosciences using a FACSCalibur™ flow cytometer
(Becton Dickinson). Online supplemental material is available at
http://www.jem.org/cgi/content/full/jem.20031973/DC1.
Results
Generation of Transgenic Mice.  To directly compare the
performance of WTpT  with TCR , constructs encoding
the TCR  component of the N15 TCR (V 8), or a
TCR /pT  hybrid molecule consisting of the extracellu-
lar domain of the N15 TCR  molecule fused to the trans-
Figure 1. Generation of transgenic mice. (A) Structures of the WTpT ,
TCR , and TCR /pT  hybrid molecules. (B) Semi-quantitative RT-PCR
analysis of primer efficiency with  -actin control. Fivefold serial dilutions
of the same sample of TCR /pT  hybrid whole thymocyte cDNA were
used in all samples. Lckp recognizes transcript p56Lck proximal promoter
sequences, mus3 recognizes WTpT  sequences, and TCRalo recognizes
TCR  sequences. (C) Semi-quantitative RT-PCR analysis of transgene
expression (top) in transgenic founders with  -actin controls (bottom).
Fivefold serial dilutions of whole thymocyte cDNA were used. (D) Total
thymocyte numbers in transgenic mice. Multiple founders of each transgenic
construct were analyzed. Mice were analyzed at 3–5 wk of age.Pre-TCR  and TCR  Are Not Interchangeable Partners of TCR  610
membrane, and cytoplasmic domains of pT  were placed
under the control of the p56Lck proximal promoter (Fig. 1
A). A previously described founder containing two to three
copies of a WTpT  transgene (F63), which was also con-
trolled by the p56Lck proximal promoter, was selected for
comparison (19, 24). This WTpT  founder was provided
by the lab of J. Nikolich-Zugich (Oregon Health and Sci-
ence University, Beaverton, OR). All founders expressing
each transgene were crossed to the pT     background.
To ensure that TCR  and TCR /pT  hybrid trans-
genes were expressed at or near levels of the WTpT 
transgene as well as physiological levels of endogenous pT 
transcripts, RNA prepared from total thymocyte suspen-
sions was analyzed by semi-quantitative RT-PCR (Fig. 1
C). A single pair of primers was used to demonstrate similar
levels of transcript expression of the WTpT  transgene in
DN3 thymocytes of this founder with those of endogenous
pT  in DN3 thymocytes of C57Bl/6 mice (19). A com-
mon 5  primer (Lckp), which recognizes a portion of the
p56Lck proximal promoter, was used to amplify all transgene
transcripts. Distinct 3  primers that recognize the cytoplas-
mic domain of pT  (mus3) and the extracellular region of
TCR  (TCRalo) were used to quantify WTpT  and
TCR  transgene transcripts. The inclusion of both of these
domains in the TCR /pT  hybrid molecule permitted use
of either 3  primer in the amplification of TCR /pT  hy-
brid transcripts. To ensure the validity of a comparison of
different transgenes amplified with distinct 3  primers, we
compared the amplification efficiency achieved by each
primer pair using the same sample of TCR /pT  hybrid
whole thymocyte cDNA as a template (Fig. 1 B). Using
these primer pairs of comparable efficiency, four founders
of TCR  transgenic mice and two founders of TCR /
pT  hybrid transgenic mice expressing transgene tran-
scripts at levels similar to those of the WTpT  transgene
(F63) were selected for analysis. With regard to surface ex-
pression of TCR , CD4 CD8 CD25 CD44   (DN3)
thymocytes from WTpT  and TCR  transgenic mice
were indistinguishable (Fig. S1 available at http://www.
jem.org/cgi/content/full/jem.20031973/DC1).
Neither TCR  nor TCR /pT  Hybrid Molecules Function-
ally Replace pT  in the pre-TCR Complex. When com-
pared in noncompetitive conditions with WTpT , neither
TCR  nor the TCR /pT  hybrid molecule successfully
recapitulated pre-TCR function. In contrast with that of the
endogenous pT  promoter, the activity of the p56Lck proxi-
mal promoter persists in the CD4 8  stage of thymocyte
development. Expression of a WTpT  transgene controlled
by the p56Lck proximal promoter resulted in a copy number–
dependent increase in apoptosis of CD4 8  thymocytes,
and a concomitant decrease in thymic cellularity (24). Al-
though this effect was severe in transgenic founders contain-
ing  20 copies of the WTpT  transgene, little or no reduc-
tion in thymic cellularity was apparent in low copy number
transgenic founders. Accordingly, the WTpT  transgenic
founder used in the present work contained two to three
transgene copies (24). Cellularity of thymi in TCR  and
TCR /pT  hybrid transgenic mice was only one third of
that in WTpT  mice (Fig. 1 D). The fraction of thymocytes
remaining at the CD4 8  stage of development was in-
creased three- to fourfold in TCR  and TCR /pT  hy-
brid thymi, whereas the proportion of thymocytes in the
CD4 8  compartment was decreased (Fig. 2 A).
To exclude the possibility that most CD4 8  thy-
mocytes in TCR  transgenic mice were generated by
transgenic TCR –endogenous TCR 4 complexes (22),
rather than by transgenic TCR –endogenous TCR 
complexes, CD4 8  thymocytes from WTpT , pT  / ,
Figure 2. Defective differentiation, cell cycle entry, and survival of thy-
mocytes expressing TCR  and hybrid transgenes. (A) Dot plots depict the
CD4 versus CD8 profile of a minimum of five 3–5-wk-old mice of each
transgenic construct. Multiple founders were analyzed. (B) Percentage of
sorted Gr-1 Ter-119 Dx5 CD19 TCR   CD4 CD8 CD25 CD44 
(DN4) thymocytes in the S/G2/M phases of the cell cycle. DNA content
was analyzed by propidium iodide staining. (C) Percentage of DN4 thy-
mocytes expressing externalized phosphatidyl serine apoptosis marker as
revealed by staining with Annexin V. (D) Percentage of CD4 8  thy-
mocytes expressing intracellular TCR  (shaded histogram). Overlay
represents intracellular staining with isotype-matched control antibody.Borowski et al. 611
and TCR  mice were stained for intracellular TCR 
chains. If the majority of CD4 8  in TCR  mice were se-
lected for progression to the CD4 8  stage by TCR  4
complexes, a large proportion of these CD4 8  would fail
to express intracellular TCR  chains (22). However,
 80% of the CD4 8  thymocytes in TCR  mice ex-
pressed intracellular TCR  (Fig. 2 D), indicating that they
were selected for progression to the CD4 8  stage by
TCR   complexes, rather than by TCR   complexes.
Pre-TCR signaling in DN3 thymocytes induces down-
regulation of CD25 surface expression, survival, entry into
the cell cycle, and progression through the DN4 stage, as
well as acquisition of CD4 and CD8 surface expression (5).
Propidium iodide staining of DN4 thymocytes sorted from
TCR  and TCR /pT  hybrid mice revealed a threefold
reduction in the proportion of this population in the
S/G2/M phases of the cell cycle (Fig. 2 B), whereas An-
nexin V staining identified a three- to fourfold increase in
the proportion of cells expressing the apoptotic surface
phenotype characterized by externalized phosphatidyl
serine (Fig. 2 C). Collectively, these data implicate deficits
in cell cycle entry and survival initiated by TCR complexes
containing TCR  or TCR /pT  hybrid molecules as two
reasons for the observed thymic hypocellularity.
Defective    T Cell Lineage Commitment Induced by TCR 
and TCR /pT  Hybrid Molecules.  In accordance with
the behavior of endogenous pT  (13, 25), provision of the
WTpT  transgene to pT     mice reduced the proportion
and absolute number of thymocytes expressing surface
TCR   complexes (19). When compared with the
CD4 8  compartment in WTpT  thymi, both the propor-
tion (Fig. 3 A) and absolute number (Fig. 3 B) of TCR   
thymocytes were elevated in mice expressing TCR  or
TCR /pT  hybrid transgenes. In contrast to the pre-
TCR, receptors substituted with TCR  and TCR /pT 
hybrid molecules lack the ability to rescue CD4 8  thy-
mocytes from commitment to the    TCR lineage.
Previous papers investigating the effects of premature
TCR  expression using TCR   (17, 18) or TCR  (15)
transgenic mice identified a population of CD4 8 
TCR  TCR    cells in some transgenic lines. However,
differences in the developmental stage at which expression
of the various TCR transgenes began made a conclusion
about the    lineage commitment capacity of TCR  
complexes difficult. To more definitively resolve this issue,
we examined the CD4 8 TCR  TCR    populations
in mice expressing WTpT  and TCR  molecules at pre-
cisely the same developmental stage. When expressed at
the pre-TCR checkpoint, the TCR  molecule generated
a four- to fivefold larger population of CD4 8 TCR  
TCR    thymocytes than does the WTpT  molecule
(Fig. 3 C), further supporting the notion that TCR  
complexes lack the robust    lineage commitment capac-
ity possessed by pre-TCR complexes.
In addition to the abnormally increased population of
CD4 8 TCR  TCR    thymocytes, an unusually large
population of CD4 8 TCR  TCR    thymocytes was
observed in mice expressing TCR  and TCR /pT 
hybrid transgenes (Fig. 3 D). In contrast to the
HSAloCD4 8 TCR  TCR    population observed in
C57Bl/6 (26) and WTpT  mice, the CD4 8 TCR  
TCR    thymocytes in TCR  and TCR /pT  hybrid
mice bore an immature HSAhi surface phenotype (Fig. 3 E).
In fact, their HSAhi surface phenotype most closely resem-
bled that of thymic HSAhi TCR    thymocytes (Fig. 3 F).
Collectively, these observations raise the possibility that
TCR   complexes may substitute more effectively for the
TCR   complex than for the pre-TCR.
Differences in Pre-TCR and TCR   Functionality Become
Much More Apparent under Competitive Conditions.  Analy-
sis of the ability of precursors expressing each transgene
merely to fill empty thymi, in an environment of unlimited
resources and niche space, might obscure functional differ-
ences between each TCR complex. To directly assess the
Figure 3. Defective    T lineage commitment induced by TCR com-
plexes containing TCR  and hybrid molecules. Proportion (A) and absolute
number (B) of CD4 8  thymocytes expressing surface TCR  . (C) Per-
centage of CD4 8  thymocytes coexpressing TCR   and TCR   on
the cell surface. (D) Histograms depict the CD4 8 TCR   population
representative of a minimum of five 3–5-wk-old mice of each transgenic
construct. Multiple founders were analyzed. (E) Surface HSA expression
on CD4 8 TCR   thymocytes in TCR  (overlay) and WTpT  (fill)
mice. (F) Surface HSA expression of CD4 8 TCR   (shaded histogram)
and CD4 8 TCR    (overlay) thymocytes in TCR  mice.Pre-TCR  and TCR  Are Not Interchangeable Partners of TCR  612
ability of TCR  and TCR /pT  hybrid molecules to
function as the partner of TCR  in the pre-TCR com-
plex, we forced precursors expressing each of these mole-
cules to compete with those expressing WTpT . To this
end, 1–2   105 lineage-negative BM cells from mice ex-
pressing TCR  TCR /pT  hybrid transgenes or pT    
mice were sorted and mixed with equal numbers of lin-
eage-negative BM cells sorted from WTpT  mice. Cross-
ing TCR , TCR /pT  hybrid, and WTpT  transgenes
onto the pT     Ly5.1 Ly5.2  or Ly5.1 Ly5.2  back-
ground allowed us to identify thymocytes derived from
each donor. Each BM cell mixture was injected into the
tail vein of irradiated Rag    c    recipients. Reconstituted
thymi were analyzed 5 wk after injection.
The differences visible between thymi of mice express-
ing WTpT  and TCR  transgenes became much more
apparent in the competition assay. Although in noncom-
petitive assays, WTpT  transgenic thymi contained on av-
erage only threefold more thymocytes than did TCR 
transgenic thymi, WTpT -derived thymocytes dominated
TCR -derived thymocytes in the competitive reconstitu-
tion assay by an average of  60-fold (Fig. 4, A and C). The
proportion of WTpT -derived donor thymocytes that
progressed to the CD4 8  developmental stage was also far
greater than that of the competing TCR -derived popula-
tion (Fig. 4 B). pT    -derived thymocytes were domi-
nated by WTpT -derived thymocytes by an average factor
of thirty (Fig. 4, A and C). This slight (twofold) difference
in performance between thymocytes derived from TCR 
and pT     BM could be the consequence of transgenesis
and was not statistically significant (P   0.09). Therefore,
provision of a TCR  transgene failed to give any competi-
tive advantage to a pT     population.
Properties Inherent to pT  Bestow Some Competitive Ability
on TCR .  In contrast with the noncompetitive analyses,
the competitive reconstitution assays revealed clear differ-
ences in the abilities of cells expressing TCR  and
TCR /pT  hybrid molecules to compete with cells ex-
pressing WTpT  molecules. In comparison with the 60-
fold domination of WTpT -derived thymocytes over
their TCR  competitors, TCR /pT  hybrid–derived
thymocytes were on average dominated by WTpT -
derived competitors by only a factor of ten (Fig. 4, A and
C). Similarly, when compared with TCR -derived thymo-
cytes, a larger proportion of TCR /pT  hybrid–derived
thymocytes progressed to the CD4 8  developmental
stage (Fig. 4 B). To confirm the significance of the pT 
cytoplasmic domain specifically at the pre-TCR check-
point, the performance of a pT  molecule lacking cyto-
plasmic proline-rich motifs was placed in direct compe-
tition with WTpT . When controlled by the p56Lck
proximal promoter, expression of this pT -PRO  on a
pT     genetic background resulted in defective   selec-
tion and    T lineage commitment (19). pT -PRO –
derived thymocytes were dominated by WTpT -derived
competitors by a factor of  100 (Fig. 4 C). The TCR /
pT  hybrid molecule mediated passage through the
CD4 8 CD25 44  (DN3) pre-TCR checkpoint as effi-
ciently as did the WTpT  molecule (Fig. 5). In contrast,
thymocytes expressing a pT  molecule lacking the pro-
line-rich region of its cytoplasmic tail (pT -PRO ) accu-
mulated at the DN3 developmental stage during forced
competition with thymocytes expressing WTpT  (Fig. 5).
Figure 4. Competitive ability of TCR , hybrid, and WTpT -derived
thymocytes. (A) Dot plots depict apparent domination of WTpT -derived
thymocytes when in direct competition with TCR  and TCR /pT 
hybrid–derived thymocytes. (B) Dot plots depict the CD4 versus CD8
surface profile of WTpT , TCR , and TCR /pT  hybrid–derived thy-
mocytes during competitive thymic reconstitution. (C) Average fold excess
of WTpT -derived thymocytes during competitive thymic reconstitution,
normalized to any fold excess CD4 8 25 44  (DN1) cells in either pop-
ulation. WTpT  versus pT     competition is included as a negative
control to illustrate background. Dots depict individual mice for each
type of competition.Borowski et al. 613
Together, these observations solidify the importance of
pT , specifically its intact cytoplasmic domain, in securing
successful passage through the pre-TCR checkpoint.
“pT -like” Performance of TCR /pT  Hybrid Molecule Is
Altered by the Presence of the Extracellular Domain of TCR .
Although the TCR /pT  hybrid performance was supe-
rior to that of the TCR  and pT -PRO  molecules, it
remained inferior to that of WTpT . As the only differ-
ence between the TCR /pT  hybrid and WTpT  mole-
cules is the presence of the extracellular domain of TCR 
in the former, perhaps properties inherent to this domain
are detrimental to the function of the pT -derived portion
of the TCR /pT  hybrid molecule.
Specifically, the more efficient pairing of TCR  with
TCR  than with pT  (27) is attributed to the presence of
a second extracellular V  domain in TCR , which is ab-
sent in pT . In addition, pairing with TCR  is influenced
by differences in the position of the interchain cystine resi-
due within the connecting peptide regions of TCR  and
pT . The addition of a V  domain to the extracellular
portion of pT  generated a molecule capable of outcom-
peting wild-type pT  for pairing with TCR  molecules in
the ER (27). The distance between the transmembrane do-
main and the cystine residue involved in covalent linkage
with TCR  is longer in TCR  than in pT . Relocation
of this TCR  cystine to the position of the pT  cystine
was accompanied by loss of efficiency in pairing with
TCR , to the degree that this mutant TCR  molecule,
when expressed in the same cell as a wild-type TCR 
molecule, could not compete for pairing with limited
TCR  molecules (27). By virtue of its TCR  extracellular
domain and connecting peptide sequence, the hybrid may
outcompete pT  for pairing to TCR  in the ER. This
higher efficiency of pairing may better protect TCR 
monomers from degradation in the ER, resulting in higher
levels of hybrid TCR complexes at the thymocyte surface.
The apparent strict regulation of pre-TCR surface expres-
sion, mediated by its constitutive internalization and ubiq-
uitin-mediated proteasome-dependent degradation (6, 7),
highlights the potential link between receptor surface level
and function. Thus, deviation from the exquisitely low
level of surface receptor expression characteristic of the
pre-TCR checkpoint could alter the intensity of signals re-
ceived by DN3 thymocytes.
Indeed, symmetrical TCR complexes containing TCR 
and TCR /pT  hybrid molecules, both of which contain a
second extracellular V  domain as well as TCR  connect-
ing peptide sequences, were expressed at levels higher than
those of normal pre-TCR complexes on the surface of the
58     T cell hybridoma (28), which is a variant of a DO-
11.10.7 mouse T cell hybridoma that does not express func-
tional TCR  or TCR  chains (Fig. 6). Thus, the possibility
exists that higher surface levels might impair the pT -like
function of TCR /pT  hybrid TCR complexes.
Discussion
Here, we show that replacement of pT  with TCR 
precisely at the pre-TCR developmental checkpoint gen-
erated a TCR   complex incapable of inducing normal  
selection processes. TCR  substitution resulted in an in-
crease in apoptosis and decrease in proliferation of DN4
thymocytes, a defect in progression to the CD4 8  devel-
opmental stage, and a failure to rescue thymocytes from the
   T cell lineage. The similarities between these defects
and those observed in pT     mice emphasize the inability
of TCR  to functionally replace pT  as the partner of
TCR  in the pre-TCR complex. Although visible in non-
competitive conditions, the differences in functional capac-
ity between pre-TCR and TCR   complexes became
much more dramatically apparent when placed in direct
competition with each other. Addition of the pT  trans-
membrane and cytoplasmic domains to the extracellular
domain of TCR  generated a TCR /pT  hybrid mole-
cule possessing enhanced abilities that became evident only
when placed in direct competition with WTpT . The
competitive performance of a pT  molecule lacking the
Figure 5. Enhanced performance of
hybrid at pre-TCR checkpoint re-
quires intact pT  cytoplasmic domain.
Percent of CD4 8  thymocytes ex-
pressing CD25 CD44  (DN3) surface
phenotype in each competing popula-
tion. Three individual mice are shown
for each competition.
Figure 6. Influence of the extracellular region of TCR  on the behavior
of the hybrid molecule. TCR  levels on the surface of the 58     T cell
hybridoma are influenced by the second extracellular domain TCR .
58     hybridoma cells were infected with retroviruses encoding
WTpT , TCR , or TCR /pT  hybrid molecules, followed by an internal
ribosomal entry site and enhanced green fluorescent protein (EGFP). Infected
cells were identified by EGFP expression. Shaded histograms represent
TCR  surface staining on cells infected with retroviruses expressing
WTpT , TCR , or TCR /pT  hybrid molecules. The overlay represents
TCR  staining on cells infected with a control retrovirus expressing
EGFP alone. The 58     T cell hybridoma is a variant of the DO-
11.10.7 mouse T cell hybridoma that does not express functional TCR 
or TCR  chains (28).Pre-TCR  and TCR  Are Not Interchangeable Partners of TCR  614
proline-rich regions of the cytoplasmic domain (pT -
PRO ) was inferior to that of both the TCR /pT  hy-
brid and TCR  molecules, suggesting that possession of an
intact pT  cytoplasmic domain was required for the im-
proved competitive ability displayed by the TCR /pT 
hybrid molecule.
Although the TCR /pT  hybrid performance was su-
perior to that of the TCR  and pT -PRO  molecules, it
remained inferior to that of WTpT . One possible expla-
nation for this discrepancy is that the higher surface expres-
sion levels of TCR /pT  hybrid TCR complexes may
impair their pT -like function (Fig. 6). The strict regula-
tion of pre-TCR surface expression, mediated by its consti-
tutive internalization and ubiquitin-mediated proteasome-
dependent degradation (6, 7), highlights the significance of
the potential link between receptor surface level and func-
tion. Alternatively, the pT -like function of TCR /pT 
hybrid TCR complexes may be affected by the strength of
association between TCR /pT  hybrid molecules and
TCR  chains. Sequences unique to the connecting peptide
of TCR , which are present in the TCR /pT  hybrid
but absent in WTpT , are required for strong association
with TCR  chains (29). Their potentially stronger associa-
tion with TCR  chains might allow TCR /pT  hybrid
TCR complexes to activate or augment signaling pathways
that are silent or attenuated during normal pre-TCR signal-
ing. A final possibility is that the second extracellular V 
domain in the TCR /pT  hybrid molecule may allow, in
addition to higher levels of surface expression, recognition
of MHC molecules in the thymic microenvironment. In
contrast, the asymmetrical nature of the pre-TCR ecto-
domain precludes recognition of MHC molecules. The ob-
served spontaneous segregation of pre-TCR complexes to
glycolipid-enriched microdomains, which contain a high
concentration of signaling molecules (2), may be involved
in the cell-autonomous nature of pre-TCR signal initia-
tion. Recognition of thymic MHC molecules might inter-
fere with spontaneous membrane segregation processes, re-
sulting in altered receptor signaling capacity.
Whether or not TCR  can substitute for pT  in the
pre-TCR complex has been a matter of some controversy
and discussion. Conflicting views placing significance ei-
ther on the receptor components themselves or on the de-
velopmental stage at which they are expressed have been
the subject of numerous investigations. However, three
factors have precluded a complete assessment of the inter-
changeability of pT  and TCR  at this point of devel-
opment.  These factors are as follows: (a) expression of
TCR  and/or TCR  transgenes at developmental stages
different than that of endogenous pT , either in the pres-
ence (15–18, 22) or absence (14) of endogenous pT ; (b)
analyses of the ability of precursors to fill empty thymi
with no competition for niche space or resources; and (c)
use of fetal thymic organ culture (FTOC) systems that may
not reveal the full proliferative potential of precursors (21).
Here, we observe the performance of a TCR  molecule
expressed in the absence of pT , at the same relevant de-
velopmental stage and RNA levels as endogenous pT , in
adult thymi, both by itself and in direct competition for
thymic space and resources.
Utilization of p56Lck proximal promoter elements en-
sured a uniform temporal regulation of WTpT , TCR ,
TCR /pT  hybrid, and pT -PRO  transgene expres-
sion. Thus, our results fail to support the notion that the
developmental stage at which the pre-TCR is expressed,
rather than the identity of the receptor components them-
selves, is the factor on which pre-TCR function is most
dependent. A recent work (21), reaching the opposite con-
clusion, compared the development of pT     fetal thy-
mocytes retrovirally transduced with either WTpT  or
TCR  in FTOC. The short time of incubation in FTOC
(2 d), which may have obscured differences in the full pro-
liferative potential of precursors retrovirally transduced
with each receptor component, raises a question regarding
the validity of the conclusion that these two molecules are
functionally equivalent at the pre-TCR checkpoint.
Its failure to rescue CD4 8  thymocytes from commit-
ment to the    T cell lineage may be perhaps the most sig-
nificant deficiency in the repertoire of “pre-TCR-like” skills
possessed by a TCR   complex. Specifically, this defect
highlights a potential reason for the precise temporal segre-
gation of pT  and TCR  expression during thymocyte de-
velopment. By virtue of its failure to direct immature
CD4 8  thymocytes through the normal   selection pro-
cesses vital to the development of mature CD4  and CD8 
T lymphocytes, a TCR  molecule expressed at the pre-
TCR checkpoint could instead direct young CD4 8  thy-
mocytes into a pathway leading to an immature   -like fate.
Our data in TCR  transgenic mice and previous data in
pT  / TCR  /  mice (14) indicate that a prematurely ex-
pressed TCR  chain can generate some limited numbers of
TCR -selected CD4 8  thymocytes and argues that the   
TCR, rather than a putative TCR 4/TCR  heterodimer
(22), is involved in the selection of CD4 8  thymocytes.
The requirement for the cytoplasmic domain of pT  at
the pre-TCR checkpoint might reside in its ability to re-
cruit the pre-TCR complex to glycolipid-enriched mem-
brane microdomains rich in signaling molecules. An inter-
action of the proline-rich region of the pT  cytoplasmic
domain with Src homology 3 domains of raft-localized Src
kinases could result in both raft localization and, via disrup-
tion of the inhibitory Src kinase intramolecular loop, in
cell-autonomous activation of Src kinase activity. Alterna-
tively, the pT  cytoplasmic domain might be required for
constitutive internalization and degradation of pre-TCR
complexes (6, 7), thereby regulating and maintaining the
exquisitely low levels of pre-TCR complexes normally ob-
served on the thymocyte surface.
Future studies analyzing differences in genetic and bio-
chemical profiles induced by expression of WTpT  and
TCR  at the pre-TCR checkpoint may provide insight as
to why TCR  is unable to substitute for pT  at this crucial
stage of thymocyte development.
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